Additional Information
Book Details
Abstract
Despite ongoing efforts to prohibit the production, storage and use of chemical warfare agents recent world events highlight the enduring threat to the population from these agents. Research efforts in various countries have resulted in novel insights into chemical warfare toxicology that has enabled the development of new approaches for the diagnosis and treatment of chemical warfare poisoning. This book provides an up-to-date treatise on the ongoing research into the toxicology of chemical warfare agents, the diagnosis and verification of exposure, and the pre- and post-exposure treatment of poisoning. Focussing on the fundamentals of the toxicology of nerve agents and vesicants, this book will give the reader a comprehensive overview of the many different aspects of chemical warfare agent toxicology. The text will appeal to toxicologists, biochemists and weapons specialists working in industry and academia, and anyone with an interest in chemical warfare toxicology or exposure.
Experts covering the broad range of topics related to CWAs author the chapters of this book. The authors are regarded as authorities in the fields of toxicology and military medicine, presenting state-of-the-art information for academic, clinical and governmental audiences.
David Oliver
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Cover | Cover | ||
Chemical Warfare Toxicology Volume 1: Fundamental Aspects | i | ||
Preface | vii | ||
References to Material in the National Archives | ix | ||
Contents | xi | ||
Chapter 1 - Development, Historical Use and Properties of Chemical Warfare Agents | 1 | ||
1.1 Introduction | 1 | ||
1.2 Brief History of CW | 2 | ||
1.2.1 Prior to 1914 | 2 | ||
1.2.2 The 1914–18 War (WWI) | 2 | ||
1.2.2.1 Overview | 2 | ||
1.2.2.2 Irritants | 3 | ||
1.2.2.3 Chlorine | 3 | ||
1.2.2.4 Phosgene | 3 | ||
1.2.2.5 Sulfur Mustard | 4 | ||
1.2.2.6 Other Agents | 4 | ||
1.2.3 The Inter-War Years | 4 | ||
1.2.4 The 1939–1945 War (WWII) | 5 | ||
1.2.5 Post WWII and the Cold War Years | 6 | ||
1.2.6 The Middle East | 7 | ||
1.2.7 Terrorism | 8 | ||
1.2.8 Chemical Weapons Convention | 8 | ||
1.3 Classification, Properties and Modes of Use of CW Agents | 9 | ||
1.3.1 Classification | 9 | ||
1.3.2 Physicochemical Properties | 9 | ||
1.3.2.1 Gaseous and Liquid Agents | 9 | ||
1.3.2.2 Solid Agents | 11 | ||
1.3.3 Ease of Production | 12 | ||
1.4 Main Classes of Chemical Agents | 12 | ||
1.4.1 Lung Injurants (Choking Agents) | 12 | ||
1.4.1.1 Chlorine | 12 | ||
1.4.1.2 Phosgene and Diphosgene | 13 | ||
1.4.1.3 Perfluoroisobutene | 13 | ||
1.4.2 Blood Agents | 13 | ||
1.4.2.1 Hydrogen Cyanide | 13 | ||
1.4.2.2 Cyanogen Chloride | 14 | ||
1.4.3 Vesicants (Blister Agents) | 14 | ||
1.4.3.1 Sulfur Mustard | 14 | ||
1.4.3.2 Nitrogen Mustards | 15 | ||
1.4.3.3 Lewisite | 16 | ||
1.4.4 Nerve Agents | 16 | ||
1.4.4.1 Tabun and DFP | 16 | ||
1.4.4.2 Sarin, Soman, Cyclosarin and 2-Methyl GF | 17 | ||
1.4.4.3 V Agents | 18 | ||
1.4.4.4 Other Nerve Agents | 18 | ||
1.4.5 Riot Control Agents | 19 | ||
1.4.6 Incapacitants | 20 | ||
1.4.7 Future Developments | 22 | ||
References | 23 | ||
Chapter 2 - Toxicology of Vesicants | 29 | ||
2.1 Introduction | 29 | ||
2.2 Sulfur Mustard | 30 | ||
2.2.1 Mechanism of Action | 30 | ||
2.2.1.1 Chemical Reactivity | 30 | ||
2.2.1.2 Alterations to DNA | 31 | ||
2.2.1.3 Alterations to Other Cellular Components and Processes | 32 | ||
2.2.2 Toxicokinetics, Metabolism and Distribution | 32 | ||
2.2.2.1 Studies in Animals | 33 | ||
2.2.2.1.1\rDermal.Cullumbine46 used a histological stain that formed an insoluble black complex with free SM, but not with degradation prod... | 33 | ||
2.2.2.1.2\rInhalation.SM is readily absorbed across the respiratory tract, including across the nasal membrane.49 Langenberg et al.50 showe... | 33 | ||
2.2.2.1.3\rOther Routes.Radioactivity appears in the kidney, lung and liver after intravenous administration of radiolabelled SM to the rab... | 33 | ||
2.2.2.2 Studies in Humans | 34 | ||
2.2.2.2.1 Dermal.Renshaw† reported that >80% of SM applied to the skin evaporates if the application site is left unoccluded,58 a... | 34 | ||
2.2.2.2.2\rOther Routes of Exposure.No systematic studies describe the kinetics of SM following other routes of exposure in humans. In part... | 34 | ||
2.2.2.3 In vitro Studies | 36 | ||
2.2.3 Acute Toxicity | 36 | ||
2.2.3.1 Studies in Animals | 36 | ||
2.2.3.1.1\rOral Exposure.There are few reports on the oral toxicity of SM. In one study, the oral lethal dose, 50% (LD50) of SM [administer... | 36 | ||
2.2.3.1.2\rDermal Exposure.Since the first research efforts in 1917–1918, a large range of animal species have been exposed to SM liquid an... | 37 | ||
Lethality.Dacre and Goldman72 reported the percutaneous LD50 of SM to be 9 mg kg−1 in the rat, 92 mg kg−1 in the mouse, 20 mg kg... | 37 | ||
Sublethal Pathology.Venkateswaran et al.74 investigated the systemic effects of sublethal percutaneous doses of SM (3.88, 7.75 o... | 37 | ||
2.2.3.1.3\rInhalation | 38 | ||
Pathology.An early study described the pathology of SM effects on the lungs in detail.75 Three groups of dogs responded in diffe... | 38 | ||
Lethality by Inhalation.There are very few quantitative determinations of the lethality of SM after inhalation exposure. Box and... | 39 | ||
2.2.3.2 Exposures of Humans | 40 | ||
2.2.3.2.1\rDermal.The acute dermal effects of SM are a primary irritancy reaction and are covered in detail in Section 2.4 | 40 | ||
2.2.3.2.2\rInhalation.There are no non-anecdotal reports of acute effects in humans by the inhalation route. The following is an account of... | 40 | ||
First World War.In a 1922, a clinical study of 83 “pensioners” with recognised disability due to gas poisoning during WWI was pe... | 42 | ||
Second World War.There were no battlefield exposures to SM during combat in WWII. However, an example of the effects of an acute... | 42 | ||
Iran–Iraq War.Over 100000 medical casualties were reported from the Iran–Iraq War with symptoms related to SM exposure. Of 61 vi... | 43 | ||
2.2.4 Irritation and Corrosiveness | 44 | ||
2.2.4.1 Studies in Animals | 44 | ||
2.2.4.1.1\rDermal.Early studies97 described similar pathology of liquid SM on the skins of rabbits, guinea pigs and cats. Within 2 hours of... | 44 | ||
2.2.4.1.2\rInhalation.Vijayaraghavan et al.83 investigated the effects of the inhalation of SM on breathing patterns in groups of four mice... | 45 | ||
2.2.4.1.3\rOcular.Warthin103 compared clinical descriptions of SM induced eye lesions in humans with the pathology of experimental lesions ... | 46 | ||
2.2.4.2 Studies in Humans | 46 | ||
2.2.4.2.1\rDermal.SM produces a dose dependent primary irritant response, erythema, oedema and vesication/desquamation when it comes into c... | 47 | ||
2.2.4.2.2\rOcular Effects.There are two key studies in human volunteers that quantify the effects of SM vapour on human eyes.106,107 Human ... | 48 | ||
2.2.5 Sensitisation | 48 | ||
2.2.5.1 Studies in Animals | 48 | ||
2.2.5.2 Studies and Exposures in Humans | 49 | ||
2.2.6 Repeated Dose Toxicity | 49 | ||
2.2.6.1 Studies in Animals | 49 | ||
2.2.6.1.1\rOral.Sasser et al.118 dosed male and female Sprague–Dawley rats (12 of each gender per dose group) with SM dissolved in sesame o... | 49 | ||
2.2.6.1.2\rInhalation.McNamara et al.80 studied 6 dogs, 12 rabbits, 30 guinea pigs, 140 rats and 140 A/J mice, housed in a chamber and cont... | 50 | ||
2.2.6.2 Studies in Humans | 51 | ||
2.2.7 Mutagenicity | 52 | ||
2.2.7.1 DNA Damage In vitro | 52 | ||
2.2.7.2 Mutagenicity Studies In vitro | 53 | ||
2.2.7.3 Mutagenicity Studies in Drosophila | 53 | ||
2.2.7.4 In vivo Studies in Mammals | 53 | ||
2.2.7.5 Studies in Humans | 53 | ||
2.2.8 Carcinogenicity | 54 | ||
2.2.8.1 Studies in Animals | 54 | ||
2.2.8.1.1\rOral.Sasser et al.119 dosed male and female Sprague–Dawley rats as described in Section 2.6.1.1 at doses of 0 (control), 0.003, ... | 54 | ||
2.2.8.1.2\rInhalation.Heston139 showed that exposure to SM vapour increased the incidence of pulmonary tumours in mice from an incidence of... | 54 | ||
2.2.8.1.3\rOther Routes of Exposure.Heston141 described studies of the incidence of pulmonary tumours in mice treated intravenously with ni... | 55 | ||
2.2.8.2 Studies in Humans | 56 | ||
2.2.8.3 Conclusions for Carcinogenicity | 57 | ||
2.2.9 Toxicity for Reproduction | 58 | ||
2.2.9.1 Studies in Animals | 58 | ||
2.2.9.1.1\rDevelopmental Toxicity.Rommereim and Hackett152 administered oral doses of SM at 0–2 mg kg−1 on gestation days 6–15 inclusive (r... | 58 | ||
2.2.9.1.2\rFertility.In a 42 week two generation study in the rat,119 groups of 27 females and 20 males/group/generation were treated by ga... | 58 | ||
2.2.9.2 Studies in Humans | 59 | ||
2.2.10 Summary of SM Toxicology | 60 | ||
2.3 Lewisite | 60 | ||
2.3.1 Toxicokinetics | 61 | ||
2.3.2 Acute Toxicity | 62 | ||
2.3.2.1 Studies in Animals | 62 | ||
2.3.2.2 Studies in Humans | 64 | ||
2.3.3 Ocular Toxicity | 65 | ||
2.3.4 Repeated Dose Toxicity | 66 | ||
2.3.5 Mutagenicity | 67 | ||
2.3.6 Toxicity for Reproduction | 67 | ||
2.3.7 Summary of L Toxicology | 68 | ||
2.4 Conclusions | 68 | ||
Acknowledgements | 69 | ||
References | 69 | ||
Chapter 3 - Toxicology of Organophosphorus Nerve Agents | 81 | ||
3.1 Introduction | 81 | ||
3.2 General Substance Information | 82 | ||
3.2.1 Physicochemical Properties | 82 | ||
3.2.2 History | 83 | ||
3.2.3 Uses | 86 | ||
3.3 Hazard Characterization of Nerve Agents | 86 | ||
3.3.1 Acute Effects of Nerve Agent Exposure | 87 | ||
3.3.2 Historical Nerve Agent Toxicity Studies | 88 | ||
3.3.2.1 Systemic Toxicity Studies | 89 | ||
3.3.2.2 Vapour Exposures | 93 | ||
3.3.2.3 Penetration of Skin and Clothing by Liquid Agents | 98 | ||
3.3.3 Other Effects of Nerve Agent Exposure | 100 | ||
3.3.4 Delayed and Long Term Effects of Nerve Agent Exposure | 101 | ||
3.3.5 Effects of Low Level Nerve Agent Exposure | 102 | ||
3.4 Human Estimates of Nerve Agent Toxicity | 104 | ||
3.5 Summary | 104 | ||
References | 107 | ||
Chapter 4 - Toxicology and Treatment of Phosgene Induced Lung Injury | 117 | ||
4.1 Introduction | 117 | ||
4.2 Properties | 119 | ||
4.2.1 Odour | 119 | ||
4.2.2 Pathophysiology | 119 | ||
4.2.2.1 Initial Reflex Syndrome | 120 | ||
4.2.2.2 Clinical Latent Phase | 121 | ||
4.2.2.3 Clinical Oedema Phase | 122 | ||
4.3 History of Use | 123 | ||
4.3.1 Warfare | 123 | ||
4.3.2 Occupational/Accidental Exposures | 124 | ||
4.4 Haber’s Law | 125 | ||
4.5 Tolerance | 127 | ||
4.6 Mechanisms of Phosgene Injury | 128 | ||
4.7 Therapeutic Research Approaches | 130 | ||
4.7.1 In vitro Studies | 131 | ||
4.7.2 Small Animal In vivo Studies | 134 | ||
4.7.3 Large Animal In vivo Studies | 136 | ||
4.8 Recent Advances | 141 | ||
4.8.1 Potential Future Therapeutic Options | 143 | ||
4.8.1.1 Stem Cells | 145 | ||
4.8.1.2 Growth Factors | 145 | ||
4.9 Conclusions | 146 | ||
Acknowledgements | 147 | ||
References | 147 | ||
Chapter 5 - Human Exposures to Sulfur Mustard | 154 | ||
5.1 Introduction | 154 | ||
5.2 Toxic Effects of SM in Humans | 155 | ||
5.2.1 Effects on the Eyes | 155 | ||
5.2.2 Effects on the Skin | 158 | ||
5.2.2.1 Vapour | 160 | ||
5.2.2.1.1\rExposure of the Forearm.Several groups have attempted to establish the threshold Ct for erythema in humans. The first systematic... | 160 | ||
5.2.2.1.2\rWhole Body Exposures | 161 | ||
Chamber Trials.In a series of chamber exposures carried out in India in 194240, men were exposed to Cts of SM from 40.9 to 176 m... | 161 | ||
5.2.2.1.3\rQuantification of Skin Burns.There have been a number of attempts to devise methods of quantifying skin burns in terms of severi... | 163 | ||
5.2.2.2 Effects of Increased Temperature on SM Injury | 163 | ||
5.2.2.3 Effects of RH on SM Injury | 164 | ||
5.2.2.4 Analytical Considerations | 165 | ||
5.2.2.5 Clothing | 166 | ||
5.2.2.5.1\rSystemic Poisoning after Vapour Exposure of the Skin.After the vapour exposures reported by Heinen et al.41 described above, no ... | 167 | ||
5.2.2.6 Liquid | 167 | ||
5.2.2.6.1\rPotency of SM on Human Skin and Sensitisation by Previous Exposure.In an early study, 302 workers at the UK defence establishmen... | 169 | ||
5.2.2.6.2\rSensitisation.The observation from early studies that individuals who had been previously exposed to SM were more sensitive than... | 172 | ||
5.3 Conclusions | 173 | ||
References | 175 | ||
Chapter 6 - Long-Term Effects of the Chemical Warfare Agent Sulfur Mustard | 179 | ||
6.1 Introduction | 179 | ||
6.2 Sulfur Mustard | 180 | ||
6.2.1 Cutaneous Injury | 181 | ||
6.2.2 Ocular Injury | 183 | ||
6.2.3 Pulmonary Injury | 185 | ||
6.2.4 Cancers | 186 | ||
References | 187 | ||
Chapter 7 - Toxicokinetics of Sulfur Mustard | 191 | ||
7.1 Introduction | 191 | ||
7.2 Experimental | 193 | ||
7.2.1 Analytical Procedures | 193 | ||
7.2.2 Animal Models | 194 | ||
7.3 Toxicokinetics of Sulfur Mustard | 195 | ||
7.3.1 Intravenous Toxicokinetics of Sulfur Mustard | 195 | ||
7.3.1.1 Rat | 196 | ||
7.3.1.2 Hairless Guinea Pig | 197 | ||
7.3.1.3 Pig | 199 | ||
7.3.1.4 Marmoset | 199 | ||
7.3.2 Subcutaneous Toxicokinetics of Sulfur Mustard | 200 | ||
7.3.2.1 Pig | 200 | ||
7.3.3 Inhalation Toxicokinetics of Sulfur Mustard | 201 | ||
7.3.3.1 Rat | 201 | ||
7.3.3.2 Hairless Guinea Pig | 202 | ||
7.3.3.3 Marmoset | 203 | ||
7.3.4 Percutaneous Toxicokinetics of Sulfur Mustard | 204 | ||
7.3.4.1 Pig | 204 | ||
7.3.4.2 Hairless Guinea Pig | 204 | ||
7.4 The Influence of Scavengers on the Toxicokinetics of Sulfur Mustard | 206 | ||
7.5 Toxicokinetics of Sulfur Mustard in Humans | 207 | ||
7.6 Conclusions | 209 | ||
References | 210 | ||
Chapter 8 - Modeling Organophosphorus Chemical Warfare Nerve Agents: A Physiologically Based Pharmacokinetic–Pharmacodynamic (PBPK-PD) Model of VX | 213 | ||
8.1 Introduction | 214 | ||
8.2 Materials and Methods | 215 | ||
8.2.1 PBPK Model Structure | 215 | ||
8.2.1.1 Routes | 217 | ||
8.2.1.2 Endpoints | 218 | ||
8.2.2 Model Parameters | 218 | ||
8.2.2.1 Physiological Parameters | 218 | ||
8.2.2.2 Chemical Specific Parameters | 222 | ||
8.2.2.3 Pharmacodynamic Parameters | 222 | ||
8.2.2.4 Dosing Parameters | 222 | ||
8.2.3 Data Used for Model Parameterization and Validation | 222 | ||
8.2.3.1 Intravenous Data | 223 | ||
8.2.3.2 Subcutaneous Data | 223 | ||
8.2.3.3 Dermal Data | 223 | ||
8.2.4 Sensitivity Analyses | 223 | ||
8.3 Results | 224 | ||
8.3.1 Simulations | 224 | ||
8.3.1.1 Data for Fitting | 224 | ||
8.3.1.2 Data for Validation | 224 | ||
8.3.2 Sensitivity Analyses | 225 | ||
8.3.2.1 Sensitivity Analyses for the Intravenous Route | 227 | ||
8.3.2.2 Sensitivity Analyses for the Subcutaneous Route | 229 | ||
8.3.2.3 Sensitivity Analyses for the Dermal Route | 230 | ||
8.4 Discussion | 231 | ||
8.4.1 PBPK Model Structure | 231 | ||
8.4.2 Model Parameters | 251 | ||
8.4.3 Simulations | 253 | ||
8.4.4 Sensitivity Analyses | 254 | ||
8.5 Conclusions | 258 | ||
Acknowledgements | 258 | ||
References | 259 | ||
Chapter 9 - Allometric Modeling of Mammalian Cyanogen Chloride Inhalation Lethality | 264 | ||
9.1 Introduction | 264 | ||
9.2 Statistical Background | 265 | ||
9.2.1 Allometric Modeling and IH Toxicology | 266 | ||
9.2.2 IH Dose–Response Statistics and the Toxic Load | 268 | ||
9.2.3 Probit Analysis Models Used for Fitting Response Data | 269 | ||
9.2.5 Healthy Subpopulation Versus General Population in Toxicity Sensitivity | 271 | ||
9.3 CK: Properties and Characteristics | 272 | ||
9.4 CK IH Toxicology | 273 | ||
9.4.1 General Toxicology | 274 | ||
9.4.2 Acute Human Toxicity | 274 | ||
9.4.3 Acute Mammalian Toxicity | 275 | ||
9.5 Previous Human Lethality Estimates for CK IH Toxicity | 282 | ||
9.5.1 UK: Porton (Unofficial) | 282 | ||
9.5.2 UK: Health Safety Executive | 282 | ||
9.6 Data Analysis and Results | 283 | ||
9.6.1 Data Reduction | 283 | ||
9.6.1.1 Calculation and Collection of Nominal LD50s | 283 | ||
9.6.1.2 Dataset Management for Probit Analysis | 283 | ||
9.6.2 PS Estimation | 284 | ||
9.6.3 Linear Regression Analysis | 286 | ||
9.6.4 Allometric Scaling of Mammalian CK Lethality | 288 | ||
9.6.5 TLE and Time–Concentration Relationship | 290 | ||
9.6.6 Human Lethality Estimates for CK IH | 291 | ||
9.6.7 Human Severe Effect Estimates for CK IH | 291 | ||
9.6.8 Comparison of Estimates: Present Chapter with Previous Work | 293 | ||
9.6.9 Comparison of CK and AC Human Lethality Estimates | 294 | ||
9.6.10 Comparison of CK and AC Mammalian Lethality | 295 | ||
9.7 Discussion and Conclusions | 298 | ||
References | 298 | ||
Subject Index | 307 |